Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients

被引：0
|
作者：
Luciano de Souza Viana
José Carlos Serufo
Manoel Otávio da Costa Rocha
Renato Nogueira Costa
Roberto Carlos Duarte
机构：
[1] Federal University of Minas Gerais,Infectious Disease and Tropical Medicine
[2] Felicio Rocho Hospital,Departments of Medical Oncology and Internal Hematology
来源：
Supportive Care in Cancer | 2008年 / 16卷
关键词：
Neutropenic fever; Infections; Fever; Neutropenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：841 / 846
页数：5
相关论文
共 50 条
  • [31] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2303 - 2308
  • [32] Procalcitonin (PCT) as an adjunct to the Multinational Association of Supportive Care in Cancer (MASCC) risk-index score in cancer patients with febrile neutropenia
    Uys, A
    Fickl, H
    Meyer, PWA
    Anderson, R
    Rapoport, BL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 759S - 759S
  • [33] Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies
    Spasova, M. I.
    Grudeva-Popova, J. G.
    Kostyanev, S. S.
    Genev, E. D.
    Stoyanova, A. A.
    Kirina, V. I.
    Moumdjiev, I. N.
    JOURNAL OF BUON, 2009, 14 (03): : 411 - 418
  • [34] Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer
    Zhang, Sheng
    Wang, Qing
    Ling, Yun
    Hu, Xichun
    BMC CANCER, 2015, 15
  • [35] Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer
    Sheng Zhang
    Qing Wang
    Yun Ling
    Xichun Hu
    BMC Cancer, 15
  • [36] Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients
    Marshall, E
    Smith, DB
    O'Reilly, SM
    Murray, A
    Kelly, V
    Clark, PI
    SUPPORTIVE CARE IN CANCER, 2000, 8 (03) : 198 - 202
  • [37] Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients
    E. Marshall
    D. B. Smith
    S. M. O'Reilly
    A. Murray
    V. Kelly
    P. I. Clark
    Supportive Care in Cancer, 2000, 8 : 198 - 202
  • [38] Transfer in ICU of febrile neutropenic patients: prospective validation of a prognostic score identifying 'high-risk' patients
    J Larché
    F Alla
    P Maurer
    O Kunzberger
    A Gérard
    Critical Care, 7 (Suppl 2):
  • [39] A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases
    Perazzoli, Camila
    Parra, Rogerio S.
    Feitosa, Marley R.
    Sfoggia, Enrico
    Simoes, Belinda Pinto
    Rocha, Jose J. R.
    Feres, Omar
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [40] Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy
    O'Neal, Richard
    Roberts, Kandice
    Chen, Quan
    Huang, Bin
    Saeed, Hayder
    Ramlal, Reshma
    Monohan, Gregory
    Hildebrandt, Gerhard C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345